Hologic, Inc. (VIE:HOLX)
Austria · Delayed Price · Currency is EUR | Market Cap | 14.70B +16.5% |
| Revenue (ttm) | 3.51B +2.2% |
| Net Income | 462.23M -26.9% |
| EPS | 2.04 -23.8% |
| Shares Out | n/a |
| PE Ratio | 31.81 |
| Forward PE | 16.89 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 65.00 |
| Previous Close | 65.50 |
| Day's Range | 65.00 - 66.00 |
| 52-Week Range | 46.20 - 66.50 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 30, 2026 |
About Hologic
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos... [Read more]
Financial Performance
In fiscal year 2025, Hologic's revenue was $4.10 billion, an increase of 1.74% compared to the previous year's $4.03 billion. Earnings were $565.70 million, a decrease of -28.35%.
Financial numbers in USD Financial StatementsNews
Blackstone, TPG seek over $4 billion for Hologic's surgical unit, FT says
Private equity groups Blackstone and TPG are seeking more than $4 billion for medical technology firm Hologic's surgical unit, the Financial Times reported on Thursday, citing people familiar with t...
Hologic's New Sustainability Report Marks 40 Years of Impact
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc., a global leader in women's health, today released its 2025 Sustainability Report. The new report coincides with Hologic's 40th anniversary and under...
Hologic to Present New Data at ASCO 2026 Demonstrating the Clinical Impact of the Breast Cancer Index® Test on Extended Endocrine Therapy Decisions
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. and its subsidiary, Biotheranostics, Inc., today announced new data demonstrating how the Breast Cancer Index® (BCI™) Test results influence extended...
OM1 Supports 650,000 Patient Real-World Regulatory Submission for FDA Approval of Hologic's Aptima HPV Assay
BOSTON--(BUSINESS WIRE)--OM1 helped power a 650,000-patient real-world evidence study supporting FDA approval of Hologic's Aptima HPV Assay for cervical cancer screening.
New Evidence Backs Hologic's AI-Powered Mammography Technology for Detecting Challenging Cancers
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #WomensHealth--Research presented at the Society of Breast Imaging (SBI) Symposium backs Hologic AI-powered mammography technology for detecting challenging cance...
Blackstone and TPG Complete Acquisition of Hologic
MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)---- $HOLX #holx--Blackstone and TPG Complete Acquisition of Hologic Accomplished MedTech leader Joe Almeida named Chi...
Casey's General Stores Set to Join S&P 500; DigitalOcean Holdings to Join S&P MidCap 400; Broadstone Net Lease to Join S&P SmallCap 600
NEW YORK, April 6, 2026 /PRNewswire/ -- S&P MidCap 400 constituent Casey's General Stores Inc. (NASD: CASY) will replace Hologic Inc. (NASD: HOLX) in the S&P 500, S&P SmallCap 600 constituent DigitalO...
Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Blackstone/TPG Acquisition.
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates
WASHINGTON--(BUSINESS WIRE)---- $HOLX #gallup--1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates.
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #FDA--Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio.
Hologic Announces Financial Results for First Quarter of Fiscal 2026
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for First Quarter of Fiscal 2026.
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026.
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #EricaWheeler--Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening.
Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #AI--Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exam...
New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test.
New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNA
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #AI--New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNA.
Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #cemark--Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking.
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025.
Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Holog...
Blackstone, TPG to Buy Hologic for Up to $18.3 Billion
Under the terms of the deal, Blackstone and TPG agreed to acquire all outstanding shares of the women's-health company for $76 apiece in cash.
Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal
Blackstone and TPG have agreed to acquire medical diagnostics firm Hologic in an up to $18.3 billion deal, the company said on Tuesday.
Hologic to be Acquired by Blackstone and TPG for up to $79 per Share
MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)---- $HOLX #aquisition--Hologic to be Acquired by Blackstone and TPG for up to $79 per Share.
Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks
The maker of women's health products rejected a $16 billion offer from the parties in May.
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025.
Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #Bacterial--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fus...